Ai-BrainScience Inc., (Office: Osaka, Japan, CEO: Kentaro Takamura Ph.D., “Ai-BrainScience” hereinafter) announce that the company’s advertisement article has been published on 1 December 2022, as part of Focal Point on Biotechnology in Osaka in the online version of Nature, a weekly international journal publishing the finest peer-reviewed research in science and technology.

The article discusses the global situation of dementia, the current cognitive assessment process, and Ai-BrainScience’s eye-tracking technology as an innovative way to assess cognitive functions. The article can be accessed here.

　1. Article page (eye-tracking)： https://www.nature.com/articles/d42473-022-00220-z

　2. Focal Pont on Biotechnology： https://www.nature.com/collections/ebfciceiea/